Article Versions Notes

Zhu C, Liu Y, Ji X, Si Y, Tao X, Zhang X, Yin L. Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies. Pharmaceutics. 2024; 16(9):1220. https://doi.org/10.3390/pharmaceutics16091220

Zhu, Chunxia, Yang Liu, Xiaojun Ji, Yaxuan Si, Xianhao Tao, Xiaohua Zhang, and Lifang Yin. 2024. "Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies" Pharmaceutics 16, no. 9: 1220. https://doi.org/10.3390/pharmaceutics16091220

Zhu, C., Liu, Y., Ji, X., Si, Y., Tao, X., Zhang, X., & Yin, L. (2024). Enhanced Antitumor Efficacy of Cytarabine and Idarubicin in Acute Myeloid Leukemia Using Liposomal Formulation: In Vitro and In Vivo Studies. Pharmaceutics, 16(9), 1220. https://doi.org/10.3390/pharmaceutics16091220